Physician

Jason Hsu, MD

According to 2025 Medicare claims, Jason Hsu, MD (NPI: 1548218787) practices ophthalmology in the Montgomery County-Bucks County-Chester County, PA market, with the plurality of this provider's patient population coming from Montgomery, PA. This provider's primary affiliated billing organization is RETINOVITREOUS ASSOCIATES LTD (NPI: 1659326452; TIN: 231932869) and primary practice location at 19446-7205.

Hsu's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,846 traditional Medicare patients, billed 54,924 HCPCS/CPT codes, and received $4,454,522 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 518 prescription claims across 205 beneficiaries totaling $24,232 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 9 records totaling $34,989. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have fallen sharply in recent years, from $43,803 to $24,232. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.6M$5.1M2015 Medicare payment: $4,019,368 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $4,399,105 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $4,490,300 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $5,016,580 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $5,127,269 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $4,349,121 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $4,570,513 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $4,480,466 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $4,519,906 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $4,454,522 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20152,18317,346$4,019,368
20162,23917,712$4,399,105
20172,12618,096$4,490,300
20182,47521,962$5,016,580
20192,09320,609$5,127,269
20201,75016,507$4,349,121
20211,85617,794$4,570,513
20221,90023,220$4,480,466
20231,90649,766$4,519,906
20241,84654,924$4,454,522

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$29K$58K2015 Drug cost: $43,803 (USD; Tot_Drug_Cst)2016 Drug cost: $40,912 (USD; Tot_Drug_Cst)2017 Drug cost: $47,503 (USD; Tot_Drug_Cst)2018 Drug cost: $58,174 (USD; Tot_Drug_Cst)2019 Drug cost: $49,829 (USD; Tot_Drug_Cst)2020 Drug cost: $52,999 (USD; Tot_Drug_Cst)2021 Drug cost: $38,648 (USD; Tot_Drug_Cst)2022 Drug cost: $25,883 (USD; Tot_Drug_Cst)2023 Drug cost: $25,417 (USD; Tot_Drug_Cst)2024 Drug cost: $24,232 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015225658$43,803
2016205610$40,912
2017200627$47,503
2018192613$58,174
2019222693$49,829
2020203570$52,999
2021219559$38,648
2022215586$25,883
2023238613$25,417
2024205518$24,232

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg3462,482$659
67028Injection of drug into eye6142,258$105
92014Established patient complete exam of visual system755784$97
92012Established patient problem focused exam of visual system9242,065$71
92134Imaging of retina1,7634,025$33

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate1687,720$7,959
Ketorolac TromethamineKetorolac Tromethamine693,305$1,386
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat674,552$965
OfloxacinOfloxacin581,830$759
Dorzolamide HclDorzolamide Hcl181,656$242

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.3$96Genentech USA, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.6$34,893Astellas Pharma Global Development
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Jason Hsu, MD?

Tedicare shows public-source Medicare data for Jason Hsu, MD (NPI 1548218787), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jason Hsu, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Jason Hsu, MD?

Jason Hsu, MD is linked to RETINOVITREOUS ASSOCIATES LTD (billing NPI 1659326452) in the available physician profile data.

Does Jason Hsu, MD have Open Payments data?

Jason Hsu, MD has 9 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.